Tudor Investment Corp ET AL purchased a new position in Plexus Corp. (NASDAQ:PLXS - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 32,187 shares of the technology company's stock, valued at approximately $5,037,000. Tudor Investment Corp ET AL owned approximately 0.12% of Plexus at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in PLXS. Pacer Advisors Inc. bought a new stake in Plexus during the 4th quarter valued at approximately $107,489,000. American Century Companies Inc. increased its position in shares of Plexus by 72.2% during the 4th quarter. American Century Companies Inc. now owns 544,017 shares of the technology company's stock valued at $85,128,000 after purchasing an additional 228,027 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Plexus by 146.9% in the fourth quarter. JPMorgan Chase & Co. now owns 258,824 shares of the technology company's stock worth $40,501,000 after buying an additional 154,003 shares during the last quarter. Fuller & Thaler Asset Management Inc. purchased a new position in Plexus during the fourth quarter worth $24,747,000. Finally, Principal Financial Group Inc. increased its position in Plexus by 3.3% during the fourth quarter. Principal Financial Group Inc. now owns 138,367 shares of the technology company's stock valued at $21,652,000 after acquiring an additional 4,445 shares during the last quarter. Institutional investors own 94.45% of the company's stock.
Plexus Stock Up 0.9 %
Shares of PLXS traded up $1.08 during midday trading on Wednesday, hitting $126.54. The company had a trading volume of 11,924 shares, compared to its average volume of 189,435. The stock has a market cap of $3.42 billion, a price-to-earnings ratio of 29.34 and a beta of 0.80. The company's 50 day moving average price is $124.19 and its 200 day moving average price is $143.62. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 52 week low of $100.96 and a 52 week high of $172.89.
Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The technology company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.54 by $0.12. Plexus had a return on equity of 10.36% and a net margin of 3.03%. The company had revenue of $980.17 million during the quarter, compared to analyst estimates of $980.07 million. During the same period in the prior year, the company earned $0.94 earnings per share. The business's revenue was up 1.4% compared to the same quarter last year. On average, equities research analysts predict that Plexus Corp. will post 5.9 EPS for the current year.
Insiders Place Their Bets
In other Plexus news, CEO Todd P. Kelsey sold 2,000 shares of the company's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $140.00, for a total transaction of $280,000.00. Following the completion of the sale, the chief executive officer now directly owns 87,665 shares in the company, valued at $12,273,100. This represents a 2.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Frank Zycinski sold 1,200 shares of the company's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $140.84, for a total transaction of $169,008.00. Following the transaction, the insider now owns 723 shares in the company, valued at approximately $101,827.32. The trade was a 62.40 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,337 shares of company stock valued at $746,924 over the last quarter. Insiders own 1.76% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on PLXS. Needham & Company LLC restated a "buy" rating and set a $162.00 target price (down previously from $172.00) on shares of Plexus in a research report on Friday, April 25th. Benchmark dropped their price target on shares of Plexus from $170.00 to $160.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Finally, Stifel Nicolaus set a $145.00 price objective on shares of Plexus in a research report on Thursday, April 24th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Plexus presently has an average rating of "Moderate Buy" and an average price target of $155.67.
View Our Latest Research Report on PLXS
Plexus Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.